2008 Annual Meeting | Incorporate Practice Guidelines and Patient Safety Measures into Your Stroke Practice
06:45 AM - 07:15 AM |
Welcome and Overview of Stroke Quality Care Issues
David Z. Wang, DO, FAHA, FAAN |
|
06:45 AM - 08:30 AM |
Breakfast
|
|
07:15 AM - 07:45 AM |
Implementing Physician Quality Reporting Initiatives
Richard M. Dubinsky, MD, MPH, FAAN |
|
07:45 AM - 08:15 AM |
Using Guidelines to Help Stroke Care
Seemant Chaturvedi, MD, FAHA, FAAN |
|
08:15 AM - 08:30 AM |
Questions and Answers
|
David Z. Wang, DO, FAHA, FAAN | Dr. Wang has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Mediwelcome. |
Seemant Chaturvedi, MD, FAHA, FAAN | Dr. Chaturvedi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Chaturvedi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Calgary. Dr. Chaturvedi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. Dr. Chaturvedi has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Ramar & Paradiso. Dr. Chaturvedi has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Cole, Scott, Kissane. The institution of Dr. Chaturvedi has received research support from NINDS. |
Richard M. Dubinsky, MD, MPH, FAAN | Dr. Dubinsky has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan Pharmaceuticals. An immediate family member of Dr. Dubinsky has stock in Abbvie and Abbott Labs. The institution of Dr. Dubinsky has received research support from CHDI. The institution of Dr. Dubinsky has received research support from Neurocrine. The institution of Dr. Dubinsky has received research support from Prilenia. The institution of Dr. Dubinsky has received research support from Sage Pharmaceuticals. |